CLDX R&D Expenses

Celldex Therapeutics Inc · R&D Expenses

CLDX logo

CLDX R&D Expenses

Latest reported$278.84M
CLDX TTM R&D Expenses ($0.00 → $278.84M)
High-resolution chart · PNG

CLDX r&d expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Celldex Therapeutics Inc R&D Expenses — Trailing twelve months (TTM) (USD)
Period endingR&D Expenses (USD)
278,840,000
265,487,000
245,100,000
215,861,000
198,193,000
182,887,000
161,159,000
145,465,000
134,737,000
122,099,000
118,011,000
110,484,000
97,521,000
92,000,000
82,258,000
74,037,000
69,522,000
61,147,000
56,811,000
70,558,000
64,209,000
65,058,000
64,033,000
45,947,000
46,340,000
43,216,000
42,672,000
43,540,000
44,357,000
55,724,000
66,448,000
78,705,000
88,702,000
92,253,000
96,171,000
97,265,000
100,359,000
101,071,000
102,725,000
102,067,000
101,714,000
102,493,000
100,171,000
103,297,000
104,826,000
102,436,000
104,381,000
95,159,000
89,391,000
80,381,000
67,401,000
63,345,000
54,697,000
50,721,000
47,400,000
43,476,000
40,301,000
36,356,000
32,440,000
29,358,000
27,979,000
28,066,000
27,651,000
23,349,000
23,375,000
23,921,000
26,168,941
31,332,777
30,717,836
30,527,502
26,328,335
22,836,481
20,667,897
18,023,860
13,545,172
14,270,656
14,229,501
13,725,771
18,066,392
16,239,277
15,414,291
14,381,384
14,063,295
15,299,944
14,514,410
14,451,218
13,873,800
11,772,100
11,476,400
10,782,000
10,021,300
10,685,300
11,598,400
12,991,400
14,708,500
18,344,300
20,554,200
21,928,300
21,495,400
18,751,800
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.